36458208|t|Clinical and genetic characteristics of amyotrophic lateral sclerosis patients with ANXA11 variants.
36458208|a|Increasing genetic evidence supports the hypothesis that variants in the annexin A11 gene (ANXA11) contribute to amyotrophic lateral sclerosis pathogenesis. Therefore, we studied the clinical aspects of sporadic amyotrophic lateral sclerosis patients carrying ANXA11 variants. We also implemented functional experiments to verify the pathogenicity of the hotspot variants associated with amyotrophic lateral sclerosis-frontotemporal dementia. Korean patients diagnosed with amyotrophic lateral sclerosis (n = 882) underwent genetic evaluations through next-generation sequencing, which identified 16 ANXA11 variants in 26 patients. We analysed their clinical features, such as the age of onset, progression rate, initial symptoms and cognitive status. To evaluate the functional significance of the ANXA11 variants in amyotrophic lateral sclerosis-frontotemporal dementia pathology, we additionally utilized patient fibroblasts carrying frontotemporal dementia-linked ANXA11 variants (p.P36R and p.D40G) to perform a series of in vitro studies, including calcium imaging, stress granule dynamics and protein translation. The frequency of the pathogenic or likely pathogenic variants of ANXA11 was 0.3% and the frequency of variants classified as variants of unknown significance was 2.6%. The patients with variants in the low-complexity domain presented unique clinical features, including late-onset, a high prevalence of amyotrophic lateral sclerosis-frontotemporal dementia, a fast initial progression rate and a high tendency for bulbar-onset compared with patients carrying variants in the C-terminal repeated annexin homology domains. In addition, functional studies using amyotrophic lateral sclerosis-frontotemporal dementia patient fibroblasts revealed that the ANXA11 variants p.P36R and p.D40G impaired intracellular calcium homeostasis, stress granule disassembly and protein translation. This study suggests that the clinical manifestations of amyotrophic lateral sclerosis and amyotrophic lateral sclerosis-frontotemporal dementia spectrum patients with ANXA11 variants could be distinctively characterized depending upon the location of the variant.
36458208	40	69	amyotrophic lateral sclerosis	Disease	MESH:D000690
36458208	70	78	patients	Species	9606
36458208	174	185	annexin A11	Gene	311
36458208	214	243	amyotrophic lateral sclerosis	Disease	MESH:D000690
36458208	304	342	sporadic amyotrophic lateral sclerosis	Disease	MESH:C531617
36458208	343	351	patients	Species	9606
36458208	489	542	amyotrophic lateral sclerosis-frontotemporal dementia	Disease	OMIM:105550
36458208	551	559	patients	Species	9606
36458208	575	604	amyotrophic lateral sclerosis	Disease	MESH:D000690
36458208	723	731	patients	Species	9606
36458208	919	972	amyotrophic lateral sclerosis-frontotemporal dementia	Disease	OMIM:105550
36458208	1009	1016	patient	Species	9606
36458208	1038	1061	frontotemporal dementia	Disease	MESH:D057180
36458208	1086	1092	p.P36R	ProteinMutation	tmVar:p|SUB|P|36|R;HGVS:p.P36R;VariantGroup:0;CorrespondingGene:311;RS#:199988035;CorrespondingSpecies:9606;CA#:5576384
36458208	1097	1103	p.D40G	ProteinMutation	tmVar:p|SUB|D|40|G;HGVS:p.D40G;VariantGroup:1;CorrespondingGene:311;RS#:1247392012;CorrespondingSpecies:9606
36458208	1156	1163	calcium	Chemical	MESH:D002118
36458208	1394	1402	patients	Species	9606
36458208	1525	1578	amyotrophic lateral sclerosis-frontotemporal dementia	Disease	OMIM:105550
36458208	1663	1671	patients	Species	9606
36458208	1781	1834	amyotrophic lateral sclerosis-frontotemporal dementia	Disease	OMIM:105550
36458208	1835	1842	patient	Species	9606
36458208	1889	1895	p.P36R	ProteinMutation	tmVar:p|SUB|P|36|R;HGVS:p.P36R;VariantGroup:0;CorrespondingGene:311;RS#:199988035;CorrespondingSpecies:9606;CA#:5576384
36458208	1900	1906	p.D40G	ProteinMutation	tmVar:p|SUB|D|40|G;HGVS:p.D40G;VariantGroup:1;CorrespondingGene:311;RS#:1247392012;CorrespondingSpecies:9606
36458208	1930	1937	calcium	Chemical	MESH:D002118
36458208	2059	2088	amyotrophic lateral sclerosis	Disease	MESH:D000690
36458208	2093	2146	amyotrophic lateral sclerosis-frontotemporal dementia	Disease	OMIM:105550
36458208	2156	2164	patients	Species	9606
36458208	Positive_Correlation	MESH:D000690	RS#:199988035;HGVS:p.P36R;CorrespondingGene:311
36458208	Positive_Correlation	OMIM:105550	RS#:199988035;HGVS:p.P36R;CorrespondingGene:311
36458208	Association	MESH:D057180	RS#:199988035;HGVS:p.P36R;CorrespondingGene:311
36458208	Association	OMIM:105550	RS#:1247392012;HGVS:p.D40G;CorrespondingGene:311
36458208	Association	MESH:D057180	RS#:1247392012;HGVS:p.D40G;CorrespondingGene:311
36458208	Positive_Correlation	MESH:D000690	RS#:1247392012;HGVS:p.D40G;CorrespondingGene:311
36458208	Association	MESH:D000690	311
36458208	Association	MESH:D000690	311
36458208	Association	OMIM:105550	311
36458208	Association	MESH:D057180	311

